News

VIVA Pharm company announces successful accomplishment of the registration process and Marketing Authorization receipt from the MH RK for antiviral immunomodulatory drug TILAXIN®.

Doctors of different specialities face clinical signs of the immune system inefficiency (primarily, it is the presence of inveterate inflammatory process or frequently recurrent diseases, such as ARD, bronchitis, herpes, furunculosis etc.). 

However, over recent years the knowledge about immune system work got deeper and new highly effective and safe drugs have been developed, the application of which is considered to be alternative to modern therapeutic strategy and allows to increase sufficiently its effectiveness.